Loading PRIMO price...
Peers are the listed companies in the exchange's own industry group: Commodity Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 14 Aug 2026), sales fell 1.2% from a year earlier to Rs 140 cr and profit rose 14.9% to Rs 4.7 cr.
Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 6 results, the share rose on 1 and fell on 5, and moved by 3% or more on 1.
Q1 FY27: results filed 14 Aug 2026. The share went from its close on 13 Aug 2026 to its close on 17 Aug 2026 -4.86%.
| Measure | FY25 | FY26 |
|---|---|---|
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | 7.6% | 7.1% |
| Debt to equityBorrowings divided by shareholders' money. Lower is safer. | 0.43x | 0.32x |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 692 Cr of assets. Its owners funded 59% of that and borrowings 19%.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs 65 Cr, spent Rs 26 Cr on plant and equipment, and cash rose by Rs 1 Cr over the year.
Rs 100 or more means every rupee of reported profit arrived as cash.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| TATACHEM Tata Chemicals Limited | 15,184 cr | - | 0.7x | -8.9% | -3.2% | 0.36 | -13.0% | +14.4% | 1.84% |
| DEEPAKFERT Deepak Fertilizers and Petrochemicals Corporation Limited | 14,422 cr | 14.7x | 2.1x | 13.2% | 11.3% | 0.73 | 8.1% | +22.5% | 0.89% |
| GNFC Gujarat Narmada Valley Fertilizers and Chemicals Limited | 7,634 cr | 7.4x | 0.8x | 11.4% | 10.4% | 0.00 | 12.3% | +39.8% | 3.41% |
| GUJALKALI Gujarat Alkalies and Chemicals Limited | 4,043 cr | 60.9x | 0.8x | 1.3% | 1.6% | 0.11 | 1.5% | +12.7% | 2.88% |
| GHCL GHCL Limited | 3,486 cr | 6.8x | 1.0x | 14.6% | 16.9% | 0.02 | 17.1% | -2.7% | 3.29% |
| JGCHEM J.G.Chemicals Limited | 2,190 cr | 29.1x | 4.1x | 14.5% | 17.1% | 0.01 | 7.3% | +44.8% | 0.18% |
| IGPL IG Petrochemicals Limited | 1,596 cr | 19.5x | 1.2x | 6.1% | 3.1% | 0.27 | 3.9% | +31.4% | 1.93% |
| TIRUMALCHM Thirumalai Chemicals Limited | 1,428 cr | - | 0.9x | -9.7% | -3.3% | 1.34 | -8.3% | +21.5% | 0.00% |
| INDOBORAX Indo Borax & Chemicals Limited | 1,298 cr | 23.0x | 3.4x | 14.6% | 17.1% | 0.00 | 24.3% | +31.3% | 0.25% |
| ANDHRSUGAR The Andhra Sugars Limited | 1,038 cr | 9.9x | 0.6x | 6.2% | 6.5% | 0.00 | 4.4% | +4.5% | 1.07% |
| OCCLLTD OCCL Limited | 833 cr | 11.1x | 1.9x | 17.3% | 12.7% | 0.20 | 12.4% | +78.5% | 1.50% |
| SRHHYPOLTD Sree Rayalaseema Hi-Strength Hypo Limited | 814 cr | 8.8x | 0.8x | 9.3% | 11.6% | 0.00 | 13.2% | +17.0% | 0.63% |
| AMNPLST Amines & Plasticizers Limited | 774 cr | 20.1x | 2.6x | 13.2% | 17.5% | 0.09 | 6.6% | +7.3% | 0.36% |
| SADHNANIQ Sadhana Nitrochem Limited | 602 cr | - | 1.3x | - | -11.9% | 0.24 | - | -3.1% | 0.00% |
| PRIMO Primo Chemicals Limited | 573 cr | 36.4x | 1.4x | 3.9% | 7.1% | 0.32 | 2.9% | -1.2% | 0.00% |
| CHEMFAB Chemfab Alkalis Limited | 452 cr | - | 1.2x | -0.1% | 1.6% | 0.33 | -0.1% | -20.1% | 0.40% |
| MANORG Mangalam Organics Limited | 402 cr | 19.7x | 1.3x | 6.5% | 15.9% | 1.12 | 3.2% | +22.2% | 0.00% |
| LORDSCHLO Lords Chloro Alkali Limited | 371 cr | 10.9x | 1.5x | 13.6% | 12.6% | 0.67 | 8.3% | +6.1% | 0.00% |
| JOCIL Jocil Limited | 118 cr | 14.3x | 0.6x | 3.9% | 5.4% | 0.00 | 0.8% | -6.3% | 0.38% |
| TECILCHEM TECIL Chemicals and Hydro Power Limited | 16 cr | - | - | - | 7.4% | - | - | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Each bar is one quarter as filed with the exchange, newest on the right, so the seasonal shape of the business is visible rather than smoothed away. Hover any quarter for its full figures and the change against the same quarter a year earlier. Revenue and profit are drawn on separate scales because they differ by an order of magnitude; reading one against the other would be misleading.
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.